Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C77178
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
||
|
WHO-ATC |
L03AX03
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
||
|
NDF-RT |
N0000183906
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
||
|
NDF-RT |
N0000183904
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
N0000183364
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | Actively Acquired Immunity [PE] | ||
|
C75774
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | |||
|
N0000010507
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | BCG Vaccine [Chemical/Ingredient] | ||
|
2XQ558L16Z
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | |||
|
DB10343
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | |||
|
N0000009357
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | Increased Immunologically Active Molecule Activity [PE] | ||
|
N0000170873
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | Vaccines, Attenuated [Chemical/Ingredient] | ||
|
221050
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | RxNorm | ||
|
2XQ558L16Z
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | |||
|
N0000183884
Created by
admin on Mon Mar 31 20:38:41 GMT 2025 , Edited by admin on Mon Mar 31 20:38:41 GMT 2025
|
PRIMARY | Increased Macrophage Proliferation [PE] |